IBA receives 1st payment from Chinese licensing deal

By AuntMinnieEurope.com staff writers

September 24, 2020 -- Proton therapy developer Ion Beam Applications (IBA) has received the first payment of 20 million euros from its strategic licensing deal with CGN Nuclear Technology Development in China.

Under the deal signed on 26 August, CGN Nuclear Technology Development and its wholly owned subsidiary CGN Dasheng received exclusive rights to distribute IBA's Proteus Plus proton therapy technology in the People's Republic of China, excluding Hong Kong, Taiwan, and Macau. The contract has a minimum value of 100 million euros, IBA said.

IBA noted that it has retained the rights to complete up to five direct ProteusPlus contracts that are currently being negotiated in China.

Copyright © 2020 AuntMinnieEurope.com

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking